Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corneal epithelial surface proteins" refers collectively to the diverse array of membrane and secreted proteins expressed on the outer layer of corneal epithelial cells. These include tight junction proteins (e.g., occludin, claudins, ZO-1), gap junction proteins (e.g., connexins), adhesion molecules, and transmembrane mucins (such as MUC16). They are critical for maintaining the corneal barrier, protecting against pathogen invasion, preserving tissue hydration and transparency, and facilitating wound healing. The complex set of these proteins comprise the structural and functional barrier of the ocular surface, mediate cell-to-cell communication, and regulate immune responses[2][4][5][6]. Note: "Corneal epithelial surface proteins" is a generic, non-canonical term that does not correspond to a specific protein, receptor, or molecular target. It encompasses many unrelated molecules with diverse roles. For structured information, individual surface proteins—such as "Mucin-16" (MUC16), "Occludin", "Claudin-1", or "Connexin-43"—must be considered, each with their own canonical form, aliases, and biology[2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal epithelial surface proteins.